The role of microRNA-5196 in the pathogenesis of systemic sclerosis.

Marzena CiechomskaPatryk ZareckiMichal MerdasJerzy SwierkotEwa MorgielPiotr WilandWlodzimierz MaslinskiKatarzyna Bogunia-Kubik

Published in: European journal of clinical investigation (2017)

These results suggest that microRNA-5196 can be used as a potential biomarker characterising SSc. Overall, this study may open new possibilities for the development of microRNA-5196-based diagnostics and therapy in early phases of SSc.

Keyphrases

systemic sclerosis
interstitial lung disease
stem cells